Correction to: Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study
Osonoi T, Saito M, Tamasawa A, Ishida H, Osonoi Y. Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study. Expert Opin Pharmacother 2014;15(10):1325-35 .
Following publication of this article, two errors have been identified.
In , under the heading ‘Time since diagnosis (years)’ in the ‘Variable’ column, ‘≤ 10 years’ should be ‘≥ 10 years’. The corrected table is shown below.
Table 1. Patient characteristics.
In the Discussion section, the sentence ‘At baseline, the daily blood glucose fluctuations were higher and the glycemic/metabolic parameters were less well controlled in patients who were not concomitantly treated with metformin than in patients not treated with metformin (data not shown)’ should have read ‘At baseline, the daily blood glucose fluctuations were higher and the glycemic/metabolic parameters were less well controlled in patients who were not concomitantly treated with metformin than in patients treated with metformin (data not shown)’.
The authors apologise for these errors.